If you’ve read my last blog, you’ll already know that I’m Team Leader of Operations and Marketing at Ingenza, a role that is incredibly busy and varied, and that I absolutely love. So it might not be surprising to hear…
Biotechnology company Ingenza is proud to be celebrating its 10th year of collaboration with Teesside-based Lucite International (LI). LI is the world’s largest producer of methyl-methacrylate (MMA) – the building block of acrylic – and has partnered with Ingenza to…
I first came across Ingenza during my PhD at the University of Strathclyde, where I was fortunate enough to work in the same research group as Ali Arnold – Head of Fermentation at Ingenza – and the company stayed on…
Dr Ian Fotheringham, Managing Director and founder of Ingenza, has been awarded an MBE for services to Industrial Biotechnology in the Queen’s Birthday Honours List. This accolade recognises Ian’s position as a well-known industrial biotechnology expert. He originally gained extensive…
Ingenza’s ambitious SYNBIOPRO project for the development of biopharmaceuticals continues to make significant progress, despite the global disruption caused by the COVID-19 pandemic. Supported by a Scottish Enterprise research and development (R&D) grant since 2018, this project has hit a…
The COVID-19 pandemic has brought the world to a standstill this year but, at Ingenza, we’ve tried to remain positive throughout and keep spirits high amongst the team. We are pleased to have been able to operate as normally as…
My route into science was less traditional than most. I joined Ingenza straight from high school in January 2012, choosing to take on a modern apprenticeship rather than starting a full-time degree. This work-based learning approach was a more appealing…
I have always been interested in figuring out how things work and solving problems, which is what initially led me to study chemistry at university. I then decided to pursue a PhD in biochemistry at the University of Strathclyde, followed…
Ingenza has reached an important milestone in its work to develop a low cost recombinant human factor VIII (rhFVIII) production process to make materials for ProFactor Pharma Ltd (PFP). The goal of this work is to enable PFP to transform…
Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Ingenza has been working closely with researchers at Oxford University…